Loading…
CIK 0002054410 • 9 13F filings • May 7, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("acorn-capital-advisors-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ACRIVON THERAPEUTICS INC | COMMON STOCK | $977K | 0.3%Prev: 1.3% | 405,237 SH | Decreased |
| ATHIRA PHARMA INC. | COMMON STOCK | $3.8M | 1.3% | 501,739 SH | New |
| AURA BIOSCIENCES INC | COM | $3.2M | 1.1% | 595,744 SH | New |
| BICARA THERAPEUTICS | COM | $10.8M | 3.7%Prev: 6.0% | 643,382 SH | Decreased+1 SH |
| BIOATLA INC | COM | $2.8M | 0.9%Prev: 1.3% | 4,835,111 SH | Increased+803,065 SH |
| CANDEL THERAPEUTICS INC | COM | $14.6M | 4.9%Prev: 9.1% | 2,580,517 SH | Decreased+640,873 SH |
| CARDIF ONCOLOGY INC | COM | $5.5M | 1.9%Prev: 3.4% | 1,962,084 SH | Decreased+519,776 SH |
| CG ONCOLOGY INC | COM | $47.0M | 15.9%Prev: 17.5% | 1,131,501 SH | Increased |
| CYBIN INC | COM NEW | $12.9M | 4.4%Prev: 3.5% | 1,573,023 SH | Increased+838,630 SH |
| JASPER THERAPEUTICS | COM | $3.3M | 1.1% | 1,786,492 SH | New |
| ONKURE THERAPEUTICS INC | CLASS A COM | $8.2M | 2.8%Prev: 5.5% | 2,839,674 SH | Decreased+1,400,000 SH |
| PROTARA THERAPEUTICS INC | COM STK | $9.3M | 3.2%Prev: 3.6% | 1,752,115 SH | Increased+472,315 SH |
| PUMA BIOTECHNOLOGY INC | COM | $24.6M | 8.3%Prev: 6.5% | 4,131,299 SH | Increased+191,247 SH |
| Q32 BIO INC. | COM | $1.6M | 0.6%Prev: 1.5% | 493,425 SH | Decreased-310,000 SH |
| TERNS PHARMACEUTICALS INC | COM | $70.5M | 23.9%Prev: 5.9% | 1,746,264 SH | Increased-225,000 SH |
| TREVI THERAPEUTICS INC | COM | $26.9M | 9.1%Prev: 4.4% | 2,144,844 SH | Increased+143,796 SH |
| UROGEN PHARMA LTD | COM | $33.9M | 11.5%Prev: 8.7% | 1,448,420 SH | Increased-67,883 SH |
| VERASTEM INC | COM | $11.3M | 3.8% | 1,469,153 SH | New |
| VYNE THERAPEUTICS INC | COM | $827 | 0.0%Prev: 0.8% | 1,425 SH | Decreased-455,545 SH |
| WHITEHAWK THERAPEUTICS INC | COM | $2.8M | 0.9% | 1,139,363 SH | New |
| X4 PHARMACEUTICALS INC | COM | $1.1M | 0.4%Prev: 2.9% | 273,349 SH | Decreased-7,037,301 SH |
| 13F-HR |
| 0001636587-25-000060 |
| $197.0M |
| View |
| Aug 14, 2026 | Q2 2026 | 13F-HR | 0001636587-26-000067 | $366.5M | View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001636587-25-000043 | $152.9M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001636587-26-000029 | $351.8M | View |
| May 19, 2025 | Q1 2025 | 13F-HR/A | 0001636587-25-000021 | $149.9M | View |